Full Name
A/Prof Allen Yeoh
Designation
Goh Foundation Associate Professor in Paediatric Oncology, NUSSenior Consultant & Head of Division of Paediatric Haematology-Oncology, NUH
Bio
A/Prof Yeoh is the principal investigator of Malaysia-Singapore ALL studies. Ma-Spore ALL successfully used minimal residual disease (MRD) to deintensify therapy. Currently, Ma-Spore ALL 2020 uses RNA-Seq and ddPCR MRD to risk stratify children and adults with B-ALL. Patients with high risk genetics or those with high middle of consolidation MRD will either receive CAR-T, BMT or high-risk chemotherapy in first complete remission. Together with Prof Dario Campana, the team successfully performed 22 CAR-T cell therapy for B-leukaemias in children and adults in Singapore. Currently, 2 CAR-T ALL trials for B and T-ALL are open.

A/Prof Yeoh received his MBBS in Yong Loo Lin School of Medicine, NUS. He did his clinical/research fellow in St Jude Children’s Research Hospital. He focuses on translational clinical research in childhood leukaemias and cost-effective care.
Allen Yeoh